Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine and Magnesium Valproate in Advanced Cervical Cancer
NCT00532818Phase 3Unknown
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Jul 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydralazine, magnesium valproate in Cervical Cancer (CC), sponsored by Instituto Nacional de Cancerología. Status: unknown.
02
Drugs
hydralazinemagnesium valproate
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00532818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532818.